BVXP Stock Overview
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Bioventix PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£46.00 |
| 52 Week High | UK£51.00 |
| 52 Week Low | UK£34.02 |
| Beta | 0.36 |
| 1 Month Change | 0% |
| 3 Month Change | 6.98% |
| 1 Year Change | 21.85% |
| 3 Year Change | 16.46% |
| 5 Year Change | 13.58% |
| Change since IPO | 2,258.97% |
Recent News & Updates
Bioventix's (LON:BVXP) Dividend Will Be £0.68
Mar 29
We Think Shareholders May Consider Being More Generous With Bioventix PLC's (LON:BVXP) CEO Compensation Package
Dec 01Recent updates
Bioventix's (LON:BVXP) Dividend Will Be £0.68
Mar 29We Think Shareholders May Consider Being More Generous With Bioventix PLC's (LON:BVXP) CEO Compensation Package
Dec 01Bioventix (LON:BVXP) Is Increasing Its Dividend To £0.62
Mar 30Bioventix (LON:BVXP) Is Increasing Its Dividend To UK£0.52
Mar 31Should Bioventix PLC (LON:BVXP) Be Part Of Your Dividend Portfolio?
Mar 29Is Now The Time To Put Bioventix (LON:BVXP) On Your Watchlist?
Mar 14What Does Bioventix's (LON:BVXP) CEO Pay Reveal?
Feb 27Shareholders of Bioventix (LON:BVXP) Must Be Delighted With Their 364% Total Return
Jan 31Is Bioventix PLC (LON:BVXP) Popular Amongst Insiders?
Jan 18
Is Bioventix PLC's (LON:BVXP) Latest Stock Performance Being Led By Its Strong Fundamentals?
Jan 06Here's How We Evaluate Bioventix PLC's (LON:BVXP) Dividend
Dec 23Does Bioventix's (LON:BVXP) CEO Salary Compare Well With Industry Peers?
Nov 28Shareholder Returns
| BVXP | GB Biotechs | GB Market | |
|---|---|---|---|
| 7D | -1.5% | -2.3% | -0.7% |
| 1Y | 21.9% | -29.4% | -1.8% |
Return vs Industry: BVXP exceeded the UK Biotechs industry which returned -29.6% over the past year.
Return vs Market: BVXP exceeded the UK Market which returned -2.4% over the past year.
Price Volatility
| BVXP volatility | |
|---|---|
| BVXP Average Weekly Movement | 3.1% |
| Biotechs Industry Average Movement | 7.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: BVXP has not had significant price volatility in the past 3 months.
Volatility Over Time: BVXP's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 12 | Peter Harrison | www.bioventix.com |
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services.
Bioventix PLC Fundamentals Summary
| BVXP fundamental statistics | |
|---|---|
| Market cap | UK£240.10m |
| Earnings (TTM) | UK£8.67m |
| Revenue (TTM) | UK£13.60m |
27.7x
P/E Ratio17.7x
P/S RatioIs BVXP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BVXP income statement (TTM) | |
|---|---|
| Revenue | UK£13.60m |
| Cost of Revenue | UK£850.45k |
| Gross Profit | UK£12.75m |
| Other Expenses | UK£4.08m |
| Earnings | UK£8.67m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.66 |
| Gross Margin | 93.75% |
| Net Profit Margin | 63.73% |
| Debt/Equity Ratio | 0% |
How did BVXP perform over the long term?
See historical performance and comparison